Discontinuation of Commercialization of Gatiflo(gatifloxacin) Tablets, a broad-spectrum antibacterial agent, in Japan
September 30, 2008
Kyorin Pharmaceutical Co., Ltd. (Tokyo, President: Itaru Kojo), a wholly owned subsidiary of Kyorin Co., Ltd., and Dainippon Sumitomo Pharma Co., Ltd. (Osaka, President: Masayo Tada) announce that they have decided to voluntarily discontinue commercialization of Gatiflo® (gatifloxacin) Tablets, a broad-spectrum antibacterial agent, in Japan as of September 30, 2008.
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.